0 CHECKOUT

PRODUCT FILTERS

REGION

37
35
35
28
28

COUNTRY

28
7
7
7
7

PRICE

0
18
27
110

PUBLISHED

10
13
87
110

PRODUCT TYPE

105
4
1

Bladder Cancer Drugs Market Research Reports

Bladder cancer is the fourth most common cancer among males in the US and due to its prevalence among the over 65s, diagnoses are set to increase in ageing populations worldwide. Reports in the Bladder Cancer section cover a variety of areas, such as the latest R&D and clinical trials taking place in universities, hospitals and other research centres around the world. Explore epidemiology, unmet needs, drug development (cytotoxic, immunotherapy agents, etc.), supply & demand, business development strategies, licensing and partnership opportunities, and the activities of key industry players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Bioniche Life Sciences, Endo Pharmaceuticals, Eli Lilly and Sanofi-Aventis. Show Less Read more

Global Bladder Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Latin America Bladder Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Middle East & Africa Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Asia-Pacific Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy, arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

North America Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Global and Chinese Methotrexate disodium salt (CAS 7413-34-5) Industry - 2016

The 'Global and Chinese Methotrexate disodium salt Industry - 2016' is a professional and in-depth study on the current state of the global Methotrexate disodium salt industry with a focus on the Chinese...

Published:  July 2016
Price:  From

Global and Chinese Mitomycin C (CAS 18451) Industry - 2016

The 'Global and Chinese Mitomycin C Industry - 2016' is a professional and in-depth study on the current state of the global Mitomycin C industry with a focus on the Chinese market. The report provides...

Published:  July 2016
Price:  From

China Cyclophosphamide Monthly Export Monitoring

" China Cyclophosphamide Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s...

Published:  July 2016
Price: 

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  July 2016
Price: 

CAS Methotrexate World Consumption Report

This CAS Methotrexate World Consumption Report provides data on the net consumption of CAS 59-05-2 - Methotrexate Substance(s) in each of the countries listed. The Substance(s) covered (Methotrexate...

Published:  July 2016
Price: 

China Methotrexate Monthly Export Monitoring

" China Methotrexate Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s...

Published:  July 2016
Price: 

China Cisplatin Monthly Export Monitoring

" China Cisplatin Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, the author conducts a series of research & analysis to locate the target commodity’s...

Published:  July 2016
Price: 

China Doxorubicin Monthly Export Monitoring

" China Doxorubicin Monthly Export Monitoring" analysis is based on the original complete China Customs transaction records, the author conducts a series of research & analysis to locate the target...

Published:  July 2016
Price: 

Global Bladder Cancer Partnering 2010 to 2016

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. -...

Published:  July 2016
Price:  From

CAS Mitomycin C World Consumption Report

This CAS Mitomycin C World Consumption Report provides data on the net consumption of CAS 50-07-7 - Mitomycin C Substance(s) in each of the countries listed. The Substance(s) covered (Mitomycin C )...

Published:  July 2016
Price: 

Global and Chinese Methotrexate disodium (CAS 7413-34-5) Industry - 2016

The 'Global and Chinese Methotrexate disodium Industry - 2016' report is a professional and in-depth study on the current state of the global Methotrexate disodium industry with a focus on the Chinese...

Published:  June 2016
Price:  From

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016 Summary ‘Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016’, provides an overview of the Muscle Invasive Bladder Cancer...

Published:  May 2016
Price:  From

Bladder Cancer - Pipeline Review, H1 2016

Bladder Cancer - Pipeline Review, H1 2016 Summary ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape. The report provides comprehensive information...

Published:  April 2016
Price:  From

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016 Summary ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review,...

Published:  April 2016
Price:  From

Global and Chinese Doxorubicin (CAS 25316-40-9) Industry - 2016

The 'Global and Chinese Doxorubicin Industry, - 2016' is a professional and in-depth study on the current state of the global Doxorubicin industry with a focus on the Chinese market. The report provides...

Published:  April 2016
Price:  From
Loading Indicator

Our Clients